Day: June 10, 2020

—Data published in Science Translational Medicine——Broad-spectrum antiviral activity against multiple RNA viruses—RESEARCH TRIANGLE PARK, N.C., June 10, 2020 (GLOBE NEWSWIRE) — BioCryst Pharmaceuticals, Inc. (Nasdaq:BCRX) today announced new data published in Science Translational Medicine show, in a primate model, that galidesivir was safe, provided post-exposure prevention of Zika viral replication across a range of doses, and rapidly reduced viral loads to undetectable levels when dosed up to 72 hours after infection with Zika virus.“Galidesivir reduced Zika virus replication from the first dose administered without impairing the adaptive immune response that protects against subsequent infection. These data provide an encouraging foundation for studying SARS-CoV-2, another RNA-replicating virus, in this same animal species,”...

Company announcement, Inside Information, Helsinki, June 10, 2020 at 21.00 PM (EEST)Nexstim Plc resolved on a new stock option plan 2020Nexstim Plc (NXTMH:HEX, NXTMS:STO) (“Nexstim” or “Company”) announces that the Board of Directors of Nexstim resolved on June 10, 2020, to launch a new stock option plan aimed at the personnel, management and other interest groups of Nexstim Plc and its subsidiaries, by virtue of an authorization granted by Annual General Meeting of Shareholders of the Company on April 30, 2020.The Company has a weighty financial reason for the issue of stock options, since the stock options are intended to form part of the incentive and commitment program for the personnel, management and other interest groups. The purpose of the stock options is to encourage the personnel, management and other...

Yhtiötiedote, Sisäpiiritieto, Helsinki, 10.6.2020 klo 21.00 (EEST)Nexstim Oyj on päättänyt uudesta optio-ohjelmasta vuodelle 2020Nexstim Oyj (NXTMH:HEX, NXTMS:STO) (”Nexstim” tai ”Yhtiö”) ilmoittaa, että Yhtiön hallitus päätti 10.6.2020 perustaa uuden optio-ohjelman Nexstim Oyj:n ja sen tytäryhtiöiden henkilöstölle, johdolle ja muille sidosryhmille varsinaisen yhtiökokouksen 30.4.2020 myöntämän valtuutuksen perusteella.Optio-oikeuksien antamiselle on Yhtiön kannalta painava taloudellinen syy, koska optio‐oikeudet on tarkoitettu osaksi henkilöstön, johdon ja muiden sidosryhmien kannustin- ja sitouttamisohjelmaa. Optio-oikeuksilla kannustetaan henkilöstöä, johtoa ja muita sidosryhmiä pitkäjänteiseen työntekoon ja yhteistyöhön omistaja-arvon kasvattamiseksi. Optio-oikeuksilla pyritään myös sitouttamaan henkilöstöä, johtoa ja sidosryhmiä...

Företagsmeddelande, Insiderinformation, Helsingfors, 10 juni 2020, kl. 21.00 (EEST)Nexstim Abp har beslutat om ett nytt aktieoptionsprogram 2020Nexstim Abp (NXTMH:HEX, NXTMS:STO) (”Nexstim” eller ”bolaget”) meddelar att bolagets styrelse beslutade 10 juni 2020 om ett nytt aktieoptionsprogram riktat till bolagets och dess dotterbolags medarbetare, ledning och andra intressegrupper med stöd av befogenheter beviljade av bolagsstämman 30 april 2020.Bolaget har vägande finansiella grunder för optionsprogrammet eftersom optionerna ska utgöra en del av incitaments- och belöningsprogrammet för medarbetarna, ledningen och intressegrupperna. Syftet med optionerna är att uppmuntra medarbetarna, ledningen och intressegrupperna till långsiktigt arbete och samarbete för att öka aktievärdet. Optionerna är också tänkta som ett sätt att knyta medarbetarna,...

Marel hf. has purchased a total of 14,331,823 own shares under a share buyback programme, that was announced on Nasdaq Iceland on 10 March 2020, which corresponds to 1.86% of issued shares in the company, for a total purchase price of ISK 8,626,325,683. The buyback programme was based on the authorisation of Marel hf.´s Annual General Meeting regarding the purchase of own shares on 6 March 2019, as renewed at Marel hf.’s Annual General Meeting on 18 March 2020.The share buyback programme has today been discontinued. The average purchase price of shares under the programme was ISK 601.90 per share corresponding to the weighted average purchase price of EUR 3.90 per share during the period. The closing price of Marel shares on Nasdaq Iceland on 11 March 2020, which was the first day of the program, was ISK 527 and the closing price of Marel...

Marel hf. hefur keypt samtals 14.331.823 eigin hluti samkvæmt endurkaupaáætlun félagsins, sem tilkynnt var um í Kauphöll þann 10. mars 2020, eða sem nemur 1,86% af útgefnum hlutum í félaginu og nemur heildarkaupverð þeirra 8.626.325.683 kr. Endurkaupaáætlunin var gerð í samræmi við þágildandi heimild aðalfundar Marel hf. þann 6. mars 2019 til kaupa á eigin bréfum, sem endurnýjuð var á aðalfundi félagsins þann 18. mars 2020.Endurkaupum samkvæmt áætluninni hefur frá og með lokun markaða í dag verið hætt og er áætluninni þar með lokið. Meðalkaupverð hlutabréfa samkvæmt áætluninni var 601,90 kr. á hlut sem samsvarar 3,90 evrum á hlut miðað við vegið meðaltal á tímabilinu. Dagslokagengi hlutabréfa í Marel þann 11. mars, sem var upphafsdagur endurkaupa samkvæmt áætluninni, var 527 kr., og dagslokagengi hlutabréfanna í dag 10. júní var 690 kr.Tilgangur...

LAS VEGAS, Nevada, June 10, 2020 (GLOBE NEWSWIRE) — Consumer Portfolio Services, Inc. (Nasdaq: CPSS) (“CPS” or the “Company”) today announced the closing of its second term securitization in 2020.  The transaction is CPS’s 36th senior subordinate securitization since the beginning of 2011 and the 19th consecutive securitization to receive a triple “A” rating from at least two rating agencies on the senior class of notes.  In the transaction, qualified institutional buyers purchased $202.3 million of asset-backed notes secured by $221.9 million in automobile receivables originated by CPS.  The sold notes, issued by CPS Auto Receivables Trust 2020-B, consist of five classes.  Ratings of the notes were provided by Standard & Poor’s and DBRS, and were based on the structure of the transaction, the historical performance of...

FRESNO, Calif., June 10, 2020 (GLOBE NEWSWIRE) — Pro Travel Network Inc., (PTVL) is a 17-year old company that had spent those 17 years of existence solely in the travel industry.  While the time spent in the industry was fruitful, there comes a time when strategies & directions change.  As of March 23rd, 2020, PTN has sold the Host Travel Agency assets to Gold Medal Solutions LLC.  The deal was in the works for over 8 months and finally came to completion.  Obviously, the timing could not have been better with the current crisis encompassing the globe and gutting the travel industry. After 17 years of operating the host travel agency we believed it was time to become more diversified for just such times as we as a humanity are experiencing today.  While the plan has been in place for nearly a year these things take time to complete. ...

RICHMOND, Calif., June 10, 2020 (GLOBE NEWSWIRE) — Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the “Company”), an industry leader in exoskeleton technology for medical and industrial use, today announced the closing of its previously announced registered direct offering of 1,747,704 shares of its common stock at a purchase price of $4.5145 per share and the concurrent private placement of warrants to purchase up to 873,852 shares of its common stock issued to the accredited investors in the registered direct offering priced at-the-market under Nasdaq Rules, for aggregate gross proceeds of approximately $7.89 million. The warrants are immediately exercisable, have an exercise price of $5.18 per share and a term of five and one-half years from the issuance date.H.C. Wainwright & Co. acted as the exclusive placement agent for...

Company announcement, inside information, Helsinki, 10 June 2020 at 8:30 pm (EEST)Nexstim Plc: Amendment of the terms of stock options programs and warrantsNexstim Plc (NXTMH:HEX, NXTMS:STO) (“Nexstim” or “the Company”) has completed a rights issue which ended on 25 May 2020 in Sweden and on 27 May 2020 in Finland, and the Board of Directors has today on 10 June 2020 resolved to amend the share subscription prices of the Company’s stock option programs 2016B-C, 2017 and 2018A as well as the exercise prices of the outstanding warrant agreements i.e. special rights to shares.According to the terms and conditions of the stock option programs and the warrant agreements, the share subscription prices shall be amended, so that the share subscription price of such stock option programs or warrants is comparable to the price prior to the subscription...